Slotkin T A, Bartolome J, Persons D, Whitmore W L
Life Sci. 1984 Sep 3;35(10):1125-31. doi: 10.1016/0024-3205(84)90078-x.
Daily administration of dicyclohexylamine (DCHA), an inhibitor of spermidine synthase, to neonatal rats produced a dose-dependent depletion of brain spermidine, accompanied by a rise in putrescine and spermine. Despite continued DCHA treatment, levels of all three polyamines returned toward normal within two weeks. alpha-Difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, had a much more profound and persistent effect on spermidine and also depleted putrescine throughout drug administration; furthermore, DFMO prevented both the elevation of putrescine caused by DCHA and the eventual restitution of spermidine levels. Although a similar pattern of effects was seen in the heart, the time course of onset of DCHA-induced alterations in polyamine levels and the rapidity of subsequent adaptation were considerably different from those in brain. The net activity of DCHA toward polyamines in developing tissues thus involves the direct actions of the drug on spermidine synthesis in combination with compensatory metabolic adjustments made by each tissue to polyamine depletion.
向新生大鼠每日给予亚精胺合酶抑制剂二环己胺(DCHA),会导致脑内亚精胺呈剂量依赖性减少,同时腐胺和精胺水平升高。尽管持续进行DCHA治疗,但在两周内所有三种多胺的水平都恢复至正常。鸟氨酸脱羧酶抑制剂α-二氟甲基鸟氨酸(DFMO)对亚精胺有更显著且持久的影响,并且在整个给药过程中也会消耗腐胺;此外,DFMO既阻止了由DCHA引起的腐胺升高,也阻止了亚精胺水平最终的恢复。虽然在心脏中观察到了类似的效应模式,但DCHA诱导的多胺水平变化的起始时间进程以及随后适应的速度与脑中的情况有很大不同。因此,DCHA对发育中组织多胺的净作用涉及该药物对亚精胺合成的直接作用,以及每个组织对多胺耗竭所进行的代偿性代谢调节。